We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.8B
AUM Growth
+$1.27B
Cap. Flow
-$817M
Cap. Flow %
-2.28%
Top 10 Hldgs %
13.63%
Holding
2,806
New
288
Increased
941
Reduced
1,236
Closed
310

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$563M
2
MCD icon
McDonald's
MCD
+$357M
3
TSLA icon
Tesla
TSLA
+$268M
4
AMD icon
Advanced Micro Devices
AMD
+$253M
5
PYPL icon
PayPal
PYPL
+$250M

Sector Composition

Rank Sector Weight
1 Technology 24.67%
2 Healthcare 17.85%
3 Industrials 11.58%
4 Financials 11.17%
5 Consumer Discretionary 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPL icon
2326
LG Display
LPL
$2.93B
$76.9K ﹤0.01%
15,500
+3,000
+24% +$15.3K
AGFS
2327
DELISTED
AgroFresh Solutions Inc
AGFS
$74.9K ﹤0.01%
+25,300
New +$63.4K
UP icon
2328
Wheels Up
UP
$200M
$74.3K ﹤0.01%
361
+19
+6% +$4.9K
INFI
2329
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$73.2K ﹤0.01%
131,900
-192,700
-59% -$164K
DMRA
2330
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.81B
$72K ﹤0.01%
2,504
-1,176
-32% -$48.8K
PDYN icon
2331
Palladyne AI
PDYN
$239M
$70.9K ﹤0.01%
+21,050
New +$180K
FBRX icon
2332
Forte Biosciences
FBRX
$1.57B
$70.9K ﹤0.01%
2,836
-3,422
-55% -$87.7K
PVLA
2333
Palvella Therapeutics
PVLA
$2.05B
$70.6K ﹤0.01%
849
-285
-25% -$22.9K
OMIC
2334
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$68.9K ﹤0.01%
1,143
-357
-24% -$23.9K
RCEL icon
2335
Avita Medical
RCEL
$142M
$68.6K ﹤0.01%
+10,400
New +$62.3K
CTHR
2336
DELISTED
Charles & Colvard Ltd
CTHR
$67.9K ﹤0.01%
8,250
-270
-3% -$2.53K
NVNO
2337
enVVeno Medical
NVNO
$6.94M
$67.8K ﹤0.01%
380
-120
-24% -$24.4K
GAIA icon
2338
Gaia
GAIA
$47.6M
$66.2K ﹤0.01%
27,800
-5,000
-15% -$12.4K
APTO
2339
DELISTED
Aptose Biosciences, Inc.
APTO
$66K ﹤0.01%
253
-53
-17% -$14.2K
WWR icon
2340
Westwater Resources
WWR
$51.6M
$64.9K ﹤0.01%
82,200
-156,000
-65% -$166K
LPCN icon
2341
Lipocine
LPCN
$17.6M
$64.6K ﹤0.01%
9,559
-2,770
-22% -$20.2K
VUZI icon
2342
Vuzix
VUZI
$187M
$61.2K ﹤0.01%
16,800
+3,700
+28% +$16.9K
APTX
2343
DELISTED
Aptinyx Inc. Common Stock
APTX
$60.7K ﹤0.01%
212,900
-9,300
-4% -$2.69K
LTRPA
2344
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$60.1K ﹤0.01%
89,800
-23,700
-21% -$22.3K
TTSH
2345
DELISTED
Tile Shop Holdings
TTSH
$60K ﹤0.01%
13,700
-6,100
-31% -$25.1K
VIRX
2346
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$59.9K ﹤0.01%
41,019
+29,919
+270% +$87.4K
MTEM
2347
DELISTED
Molecular Templates, Inc.
MTEM
$59.6K ﹤0.01%
12,122
-4,647
-28% -$38.5K
FSM icon
2348
Fortuna Silver Mines
FSM
$2.55B
$59.3K ﹤0.01%
+15,800
New +$52.2K
ELDN icon
2349
Eledon Pharmaceuticals
ELDN
$262M
$58.4K ﹤0.01%
25,600
-16,600
-39% -$41K
BRLT icon
2350
Brilliant Earth
BRLT
$18.4M
$58.2K ﹤0.01%
13,500
-5,600
-29% -$33.5K

Similar funds

Two Sigma Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, Two Sigma Advisers held 2,806 positions worth $35.8B, up 3.7% from $34.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Two Sigma Advisers's Q4 2022 filing shows 288 new, 941 increased, 1,236 reduced and 310 closed positions. Its largest new stake was Advanced Micro Devices: 3,833,640 shares worth $248M. The largest sale was JPMorgan Chase, an estimated $485M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Two Sigma Advisers's largest Q4 2022 buy was Advanced Micro Devices: 3,833,640 shares worth $248M.
  • Two Sigma Advisers added most to Amazon in Q4 2022, an estimated $563M increase.
  • Two Sigma Advisers's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $485M.
  • Two Sigma Advisers fully exited NVIDIA in Q4 2022, selling an estimated $140M.
  • Two Sigma Advisers's ten largest holdings make up 14% of its $35.8B portfolio in Q4 2022.
  • Two Sigma Advisers opened 288 new positions and closed 310 in Q4 2022.
  • Two Sigma Advisers's portfolio value rose 3.7% quarter-over-quarter to $35.8B.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.